The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes.

Cavallo K, Nilubol N

Open source

DOI
10.3390/biomedicines14092105
Published
2026 Sep 18
Container
Biomedicines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14092105,
  title = {The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes.},
  author = {Cavallo K and Nilubol N},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14092105},
  url = {https://doi.org/10.3390/biomedicines14092105}
}

RIS

TY  - JOUR
TI  - The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes.
AU  - Cavallo K
AU  - Nilubol N
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14092105
UR  - https://doi.org/10.3390/biomedicines14092105
ER  - 

APA

K, C., & N, N. (2026). The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes.. Biomedicines. https://doi.org/10.3390/biomedicines14092105

Source records